Package 58468-0080-1

{"route": ["INTRAVENOUS"], "spl_id": "5c65708a-7f79-4d63-b4a9-b2b1a2d86bdd", "openfda": {"nui": ["N0000184163", "N0000178327", "N0000009689", "N0000020023", "M0011122"], "unii": ["D7RD81HE4W"], "rxcui": ["107047", "107050"], "spl_set_id": ["bbd8ab99-552e-4b81-aca4-6b0c7af8b9ae"], "pharm_class_cs": ["Immunoglobulins [CS]"], "pharm_class_pe": ["Lymphocyte Function Alteration [PE]", "Increased T Lymphocyte Destruction [PE]"], "pharm_class_epc": ["Immunoglobulin G [EPC]"], "pharm_class_moa": ["Antibody-Surface Protein Interactions [MoA]"], "manufacturer_name": ["Genzyme Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (58468-0080-1)  / 5 mL in 1 VIAL, GLASS", "package_ndc": "58468-0080-1", "marketing_start_date": "19981230"}], "brand_name": "Thymoglobulin", "product_id": "58468-0080_5c65708a-7f79-4d63-b4a9-b2b1a2d86bdd", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Antibody-Surface Protein Interactions [MoA]", "Immunoglobulin G [EPC]", "Immunoglobulins [CS]", "Increased T Lymphocyte Destruction [PE]", "Lymphocyte Function Alteration [PE]"], "product_ndc": "58468-0080", "generic_name": "Anti-thymocyte Globulin (Rabbit)", "labeler_name": "Genzyme Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Thymoglobulin", "active_ingredients": [{"name": "LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN", "strength": "5 mg/mL"}], "application_number": "BLA103869", "marketing_category": "BLA", "marketing_start_date": "19981230", "listing_expiration_date": "20271231"}